Wiley expands leadership with appointment of Karen N. Madden to Board of Directors
Wiley has appointed Karen N. Madden, Ph.D., to its Board of Directors. Madden is the Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science division of Merck KGaA, Darmstadt, Germany.
At MilliporeSigma, Madden is responsible for overseeing the company’s technology strategy and long-term research and development (R&D) initiatives. She leads the Life Science Innovation Board and helps balance high-impact, long-term projects with short-term growth strategies. Additionally, she is part of the company’s executive leadership team, which oversees the governance of its $9 billion life sciences business.
Matthew Kissner, President and CEO of Wiley, said:
“Dr. Madden's extensive experience in science, technology, and innovation makes her an exceptional addition to our Board of Directors. Her strategic vision, expertise in driving innovation, and experience across the research and development process will be invaluable as we continue to transform our business and deliver trusted content and services that drive progress.”
Background in Scientific Innovation
Madden has an extensive background in scientific research and technology development. Before joining MilliporeSigma, she served as Senior Vice President and Chief Innovation Officer at PerkinElmer, where she led innovation efforts across multiple business sectors. She also actively engages with universities, startups, and industry organizations to strengthen collaborations within the scientific community. In addition to her corporate leadership roles, she represents Merck KGaA, Darmstadt, Germany, as the U.S. Country Speaker, facilitating strategic initiatives among the company’s U.S.-based employees.
Madden said:
“I am honored to join Wiley's Board of Directors and contribute to an organization that for 218 years has helped shape global knowledge. In today's information landscape, Wiley's role in bringing vital research to the world and leveraging its authoritative content and data to benefit society resonates deeply with me. I look forward to helping the company continue to innovate and grow.”
She serves on the boards of the Analytical, Life Science, and Diagnostics Association, the New England Council, and the Greater Boston Chamber of Commerce.
Jesse Wiley, Chair of Wiley’s Board, said:
“Karen brings a wealth of knowledge in R&D and innovation that will be tremendously valuable to Wiley. Her connection to the global research community and expertise in science and technology align perfectly with our commitment to advancing knowledge. We're thrilled to welcome her to our Board.”
